As TNF-α blockade is reported to lower IL-1β in addition to neutralizing the effects of TNF-α, SARM protein expression during the initiation of anti-TNF-α biological therapy was investigated in RA peripheral blood monocytes [3, 4, 24]. The gene discussed is SARM1; the disease is rheumatoid arthritis.